圈門(mén)策略：

小鼠心臟細(xì)胞流式分選或分析需根據(jù)細(xì)胞類型、實(shí)驗(yàn)?zāi)康倪x擇合適的圈門(mén)策略。以下是關(guān)鍵要點(diǎn)和方案。

巨噬細(xì)胞圈門(mén)策略：

?表面標(biāo)志物選擇?：CD11b（單核/巨噬細(xì)胞標(biāo)志）結(jié)合F4/80（巨噬細(xì)胞特異性抗原）可有效區(qū)分巨噬細(xì)胞群體。 ?

?散射參數(shù)?：前向散射（FSC）和側(cè)向散射（SSC）可輔助篩選細(xì)胞大小和復(fù)雜度，排除雜質(zhì)細(xì)胞。 ?

?補(bǔ)償調(diào)節(jié)?：需對(duì)FITC、PE等熒光染料進(jìn)行補(bǔ)償設(shè)置，避免信號(hào)溢漏導(dǎo)致假陽(yáng)性。 ?

論文信息：

論文題目：Cardiac macrophages prevent sudden death during heart stress

期刊名稱：Nature Communications

時(shí)間期卷：12, Article number: 1910 (2021)

在線時(shí)間：2021年3月26日

DOI：doi.org/10.1038/s41467-021-22178-0

產(chǎn)品信息：

貨號(hào)：CP-005-005

規(guī)格：5ml+5ml

品牌：Liposoma

產(chǎn)地：荷蘭

名稱：Clodronate Liposomes& Control liposomes

辦事處：Target Technology(靶點(diǎn)科技)

Clodronate Liposomes氯膦酸鹽脂質(zhì)體清除肝臟和腫瘤巨噬細(xì)胞，疾病模型為：肺動(dòng)脈環(huán)縮術(shù)(pulmonary artery banding, PAB)模型。Pulmonary artery banding (PAB) 是通過(guò)環(huán)束帶限制肺動(dòng)脈血流的姑息性手術(shù)，主要用于治療先天性心臟病，如室間隔缺損、大動(dòng)脈轉(zhuǎn)位等伴隨過(guò)度肺血流的疾病。 ?原理: 該手術(shù)通過(guò)聚四氟乙烯帶環(huán)束肺動(dòng)脈主干，降低肺動(dòng)脈壓力和血流量，緩解心臟負(fù)擔(dān)。早期作為復(fù)雜先心病分期治療的過(guò)渡手段，現(xiàn)僅用于多發(fā)性室間隔缺損、合并主動(dòng)脈縮窄等特殊病例。荷蘭Liposoma巨噬細(xì)胞清除劑Clodronate Liposomes見(jiàn)刊于Nature Communications：心臟巨噬細(xì)胞在心臟壓力期間防止猝死。

Liposoma巨噬細(xì)胞清除劑Clodronate Liposomes氯膦酸二鈉脂質(zhì)體的材料和方法文字描述：

Animal studies

Male C57BL6/J mice were purchased from CLEA Japan and Jackson Laboratory and maintained on a standard mouse chow diet under sterile barrier conditions, on a 12-h light-dark cycle with 18–23?°C and 40–60% humidity. Male Areg homozygous null (Areg?/?) mice were backcrossed to C57BL6/J mice over ten generations. Rag2?/?, Cd4?/?, and Cd8a?/? mice were purchased from Taconic (Germantown, NY). The genotypes of all mice were determined using genomic PCR. The isoproterenol challenge entailed bolus administration of isoproterenol (Sigma) 5?mg/kg intraperitoneally under constant ECG recording. Clodronate liposomes and control liposomes were purchased from LIPOSOMA B.V. A total of 10?μl of clodronate or control liposome solution per gram of mouse were intravenously administrated 24?h before PAB. After the first administration of clodronate or control liposomes, the same volume of liposomes was also administrated every 7 days for long term depletion, per the manufacturer’s instructions. All protocols for animal experiments were approved by the Animal Care and Use Committee of the University of Tokyo.

Liposoma巨噬細(xì)胞清除劑Clodronate Liposomes氯膦酸二鈉脂質(zhì)體的材料和方法文獻(xiàn)截圖：